Comparison of the effects of sugamadex dosage on the reversal of neuromuscular blockadeand recovery profile in adult patients under general anesthesia
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0008773
- Lead Sponsor
- Konyang University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
1. Patients scheduled for surgery under general anesthesia
2. American Society of Anesthesiologist Patient Status I~II
(I is a normal healthy patient, II is patient with mild systemic disease).
3. 19~ 65 year old
4. Body weight equal to or less than 90kg
Exclusion Criteria
- Contraindications to the use of sugammadex
- Body mass index >30 kg/m2
- Neuromuscular disease
- Moderate or severe liver, kidney, heart, or respiratory disease
- Cognitive impairment
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method speed of reversal of neuromuscular block (i.e. time to reach train-of-four [TOF] ratio 0.9)
- Secondary Outcome Measures
Name Time Method Time required for endotracheal tube extubation after administration of sugammadex